The FDA’s decision, made on 12/19, could lead to:
💲💲Patients facing higher costs and tougher access to tirzepatide, the active ingredient in Mounjaro and Zepbound.
❌A halt to cheaper copies of the drug, known as compounded tirzepatide.
💉 A precedent for how the FDA handles other drugs, such as semaglutide!
If this is YOU?? It’s time to MAKE A PLAN!!
👉If you’ve been using tirzepatide (or a compounded version) for weight loss, you’ve probably heard the FDA is shutting down access to the cheaper compounded options in the next couple of months. That means if the price of the branded meds (like Zepbound) may be out of reach!!
My suggestion? DON’T WAIT until the meds are gone to figure it out. Start now with something that WORKS. We are seeing LOTS of new and returning clients come back to our “gold standard” weight loss plans. Both are awesome options to transition off GLP-1s if staying on them isn’t in the cards, or price and access becomes a challenge!!
💉If you can stick with the meds, our new ASCEND line is perfect for helping you maximize their benefits while building sustainable habits.
☝️ The key is to start while you’re still on the shot so the transition is smooth and stress-free. We are currently helping SO many on the medications eat correctly, prioritize protein and build healthy habits…and are doing so well they are now transitioning off of the shots!! 🙌
Don’t let the FDA’s decision leave you stuck-get ahead of it and set yourself up for success today!